Cystic Fibrosis Lung: Clinical Trials

5 trials for Cystic Fibrosis Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 22Completed 1, Recruiting 1

Follow Cystic Fibrosis Lung: new trials by email Literature Review of Cystic Fibrosis Lung trials Research Report on Cystic Fibrosis Lung

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
RSP-1502, Tobramycin inhalation solution - Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic
Phase 1 / Phase 2CompletedRespirion Pharmaceuticals Pty Ltd712024-04-012026-06-25
4D-710 in Adult Patients With Cystic Fibrosis
4D-710 - Cystic Fibrosis Lung
Phase 2Recruiting4D Molecular Therapeutics302022-03-292026-07-06
Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
Luminex; scRNAsec - Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis Lung
RecruitingOspedale San Raffaele402021-04-082024-05-16
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
Inhaled SNSP113, Inhaled Placebo - Lung Diseases, Pulmonary Disease
Phase 1TerminatedSynspira, Inc.322017-09-282018-05-25
Estimated Impact of Fungal Colonization in Cystic Fibrosis From Secondary Exploitation of MucoFong Database.
Cystic Fibrosis Lung
CompletedUniversity Hospital, Bordeaux572017-07-132019-05-06

Narrower conditions

Cystic Fibrosis (5)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Burkholderia Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Mycobacterium Infections, Nontuberculous (1)  ·  Pneumonia (1)  ·  Pseudomonas Infections (1)  ·  Recurrence (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Digestive System Diseases (5)  ·  Genetic Diseases, Inborn (5)  ·  Infant, Newborn, Diseases (5)  ·  Pancreatic Diseases (5)  ·  Lung Diseases (4)  ·  Respiratory Tract Diseases (4)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Actinomycetales Infections (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)

Sponsors

4D Molecular Therapeutics (1)  ·  Ospedale San Raffaele (1)  ·  Respirion Pharmaceuticals Pty Ltd (1)  ·  Synspira, Inc. (1)  ·  University Hospital, Bordeaux (1)

Countries

United States (2)  ·  Australia (1)  ·  France (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Maria Theresa Basco, MD, MPH (1)  ·  Sam Moskowitz MD (1)

Results publications

PMID 41124321